Da-Qiang Li (Daqiang Li)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Topics

Binding Protein

Breast Cancer Cells

Top Venues

Clinical and translational medicine

Science advances

Cancer research

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Min-Ying Huang, Shu-Yuan Hu, Jia Dong, Ling Deng, Lisa Andriani, Xiao-Yan Ma, Yin-Ling Zhang, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast Cancer. Cancer research 84 (16) (2024)
Min-Ying Huang, Shu-Yuan Hu, Jia Dong, Ling Deng, Lisa Andriani, Xiao-Yan Ma, Yin-Ling Zhang, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast Cancer. Cancer research (2024)
Ling Deng, Li Liao, Yin-Ling Zhang, Shao-Ying Yang, Shu-Yuan Hu, Lisa Andriani, Yun-Xiao Ling, Xiao-Yan Ma, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1. Science advances 10 (14) (2024)
Ling Deng, Li Liao, Yin-Ling Zhang, Shao-Ying Yang, Shu-Yuan Hu, Lisa Andriani, Yun-Xiao Ling, Xiao-Yan Ma, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1. Science advances 10 (14) (2024)
Ling Deng, Li Liao, Yin-Ling Zhang, Shao-Ying Yang, Shu-Yuan Hu, Lisa Andriani, Yun-Xiao Ling, Xiao-Yan Ma, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1. Science advances 10 (14) (2024)
Min-Ying Huang, Shu-Yuan Hu, Jia Dong, Ling Deng, Lisa Andriani, Xiao-Yan Ma, Yin-Ling Zhang, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast Cancer. Cancer research 84 (16) (2024)
Shao-Ying Yang, Li Liao, Shu-Yuan Hu, Ling Deng, Lisa Andriani, Tai-Mei Zhang, Yin-Ling Zhang, Xiao-Yan Ma, Fang-Lin Zhang, Ying-Ying Liu, Da-Qiang Li
ETHE1 Accelerates Triple-Negative Breast Cancer Metastasis by Activating GCN2/eIF2α/ATF4 Signaling. International journal of molecular sciences 24 (19) (2023)
Li Liao, Ling Deng, Yin-Ling Zhang, Shao-Ying Yang, Lisa Andriani, Shu-Yuan Hu, Fang-Lin Zhang, Zhi-Min Shao, Da-Qiang Li
C9orf142 transcriptionally activates MTBP to drive progression and resistance to CDK4/6 inhibitor in triple-negative breast cancer. Clinical and translational medicine 13 (11) (2023)
Shu-Yuan Hu, Jin-Xian Qian, Shao-Ying Yang, Lisa Andriani, Li Liao, Ling Deng, Min-Ying Huang, Yin-Ling Zhang, Fang-Lin Zhang, Zhi-Min Shao, Da-Qiang Li
Destabilization of microrchidia family CW-type zinc finger 2 via the cyclin-dependent kinase 1-chaperone-mediated autophagy pathway promotes mitotic arrest and enhances cancer cellular sensitivity to microtubule-targeting agents. Clinical and translational medicine 13 (3) (2023)
Shu-Yuan Hu, Jin-Xian Qian, Shao-Ying Yang, Lisa Andriani, Li Liao, Ling Deng, Min-Ying Huang, Yin-Ling Zhang, Fang-Lin Zhang, Zhi-Min Shao, Da-Qiang Li
Destabilization of microrchidia family CW-type zinc finger 2 via the cyclin-dependent kinase 1-chaperone-mediated autophagy pathway promotes mitotic arrest and enhances cancer cellular sensitivity to microtubule-targeting agents. Clinical and translational medicine 13 (3) (2023)
Shu-Yuan Hu, Jin-Xian Qian, Shao-Ying Yang, Lisa Andriani, Li Liao, Ling Deng, Min-Ying Huang, Yin-Ling Zhang, Fang-Lin Zhang, Zhi-Min Shao, Da-Qiang Li
Destabilization of microrchidia family CW-type zinc finger 2 via the cyclin-dependent kinase 1-chaperone-mediated autophagy pathway promotes mitotic arrest and enhances cancer cellular sensitivity to microtubule-targeting agents. Clinical and translational medicine 13 (3) (2023)
Tai-Mei Zhang, Li Liao, Shao-Ying Yang, Min-Ying Huang, Yin-Ling Zhang, Ling Deng, Shu-Yuan Hu, Fan Yang, Fang-Lin Zhang, Zhi-Min Shao, Da-Qiang Li
TOLLIP-mediated autophagic degradation pathway links the VCP-TMEM63A-DERL1 signaling axis to triple-negative breast cancer progression. Autophagy (2022)
Yin-Ling Zhang, Jin-Ling Cao, Ye Zhang, Li Liao, Ling Deng, Shao-Ying Yang, Shu-Yuan Hu, Yan Ning, Fang-Lin Zhang, Da-Qiang Li
RNF144A exerts tumor suppressor function in breast cancer through targeting YY1 for proteasomal degradation to downregulate GMFG expression. Medical oncology (Northwood, London, England) 39 (4) (2022)
Yanni Huang, Yizi Zheng, Ling Yao, Feng Qiao, Yifeng Hou, Xin Hu, Da-Qiang Li, Zhi-Ming Shao
RNA binding protein POP7 regulates ILF3 mRNA stability and expression to promote breast cancer progression. Cancer science 113 (11) (2022)
Fan Yang, Rui Sun, Zeng Hou, Fang-Lin Zhang, Yi Xiao, Yun-Song Yang, Shao-Ying Yang, Yi-Fan Xie, Ying-Ying Liu, Cheng Luo, Guang-Yu Liu, Zhi-Min Shao, Da-Qiang Li
HSP90 N-terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2-driven breast cancer progression. Clinical and translational medicine 12 (5) (2022)
Ying-Ying Liu, Hong-Yi Liu, Tian-Jian Yu, Qin Lu, Fang-Lin Zhang, Guang-Yu Liu, Zhi-Ming Shao, Da-Qiang Li
O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression. Cell death and differentiation 29 (4) (2022)
Li Liao, Yin-Ling Zhang, Ling Deng, Chao Chen, Xiao-Yan Ma, Lisa Andriani, Shao-Ying Yang, Shu-Yuan Hu, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
Protein phosphatase 1 subunit PPP1R14B stabilizes STMN1 to promote progression and paclitaxel resistance in triple-negative breast cancer. Cancer research (2022)
Hong-Yi Liu, Ying-Ying Liu, Yin-Ling Zhang, Yan Ning, Fang-Lin Zhang, Da-Qiang Li
Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage. Cell communication and signaling : CCS 20 (1) (2022)
Fang-Lin Zhang, Da-Qiang Li
Targeting Chromatin-Remodeling Factors in Cancer Cells: Promising Molecules in Cancer Therapy. International journal of molecular sciences 23 (21) (2022)
Yin-Ling Zhang, Ling Deng, Li Liao, Shao-Ying Yang, Shu-Yuan Hu, Yan Ning, Fang-Lin Zhang, Da-Qiang Li
Chromatin complexes subunit BAP18 promotes triple-negative breast cancer progression through transcriptional activation of oncogene S100A9. Cell death & disease 13 (4) (2022)
Shao-Ying Yang, Yi-Fan Xie, Tai-Mei Zhang, Ling Deng, Li Liao, Shu-Yuan Hu, Yin-Ling Zhang, Fang-Lin Zhang, Da-Qiang Li
Inositol monophosphatase 1 (IMPA1) promotes triple-negative breast cancer progression through regulating mTOR pathway and EMT process. Cancer medicine (2022)
Yi Xiao, Ding Ma, Yun-Song Yang, Fan Yang, Jia-Han Ding, Yue Gong, Lin Jiang, Li-Ping Ge, Song-Yang Wu, Qiang Yu, Yang Zhang, François Bertucci, Qiuzhuang Sun, Xin Hu, Da-Qiang Li, Zhi-Ming Shao, Yi-Zhou Jiang
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer. Cell research 32 (5) (2022)
Ying Liang, Qi Lu, Wei Li, Dapeng Zhang, Fanglin Zhang, Qingping Zou, Lu Chen, Ying Tong, Mengxing Liu, Shaoxuan Wang, Wenxuan Li, Xiaoguang Ren, Peng Xu, Zhicong Yang, Shihua Dong, Baolong Zhang, Yanni Huang, Da-Qiang Li, Hai-Lin Wang, Wenqiang Yu
Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network. Nucleic acids research 49 (15) (2021)
Qin Lu, Fang-Lin Zhang, Da-Yun Lu, Zhi-Ming Shao, Da-Qiang Li
USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells. Cancer medicine 8 (15) (2019)
Xi Jin, Xiao-En Xu, Yi-Zhou Jiang, Yi-Rong Liu, Wei Sun, Ya-Jie Guo, Yi-Xing Ren, Wen-Jia Zuo, Xin Hu, Sheng-Lin Huang, Hong-Jie Shen, Fei Lan, Yun-Fei He, Guo-Hong Hu, Gen-Hong Di, Xiang-Huo He, Da-Qiang Li, Suling Liu, Jinha Yu
The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation. Science advances 5 (3) (2019)
Hong-Yan Xie, Tai-Mei Zhang, Shu-Yuan Hu, Zhi-Ming Shao, Da-Qiang Li
Dimerization of MORC2 through its C-terminal coiled-coil domain enhances chromatin dynamics and promotes DNA repair. Cell communication and signaling : CCS 17 (1) (2019)
Ye Zhang, Yin-Long Yang, Fang-Lin Zhang, Xiao-Hong Liao, Zhi-Min Shao, Da-Qiang Li
Epigenetic silencing of RNF144A expression in breast cancer cells through promoter hypermethylation and MBD4. Cancer medicine 7 (4) (2018)